LARS2 anticorps (N-Term)
Aperçu rapide pour LARS2 anticorps (N-Term) (ABIN207518)
Antigène
Voir toutes LARS2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Synthetic peptide corresponding to N-terminal residues of human LARS2 (Probable leucyl-tRNA synthetase, mitochondrial precursor)
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide from human LARS2.
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: ELISA (1 μg/mL), WB (1 μg/mL)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.01 % sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- LARS2 (Leucyl-tRNA Synthetase 2, Mitochondrial (LARS2))
-
Autre désignation
- LARS2 / LEURS1
-
Sujet
-
Name/Gene ID: LARS2
Synonyms: LARS2, Leucyl-tRNA synthetase, LEURS, Leucine translase, KIAA0028 -
ID gène
- 23395
-
UniProt
- Q15031
Antigène
-